methandrostenolone has been researched along with DDD MPGNII in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedek, S; Kaszás, I; Kovács, A; Révai, T; Sápi, Z; Virányi, M; Winkler, G | 1 |
1 other study(ies) available for methandrostenolone and DDD MPGNII
| Article | Year |
|---|---|
[Severe nephrotic syndrome in a young man taking anabolic steroid and creatine long term].
Topics: Adult; Anabolic Agents; Creatine; Drug Administration Schedule; Glomerulonephritis, Membranoproliferative; Humans; Male; Methandrostenolone; Nephrotic Syndrome; Self Administration; Severity of Illness Index; Time Factors | 2003 |